Comparison of cost-effectiveness of regorafenib and trifluridine/tipiracil combination tablet for treating advanced and recurrent colorectal cancer

Regorafenib and trifluridine/tipiracil combination tablet regimens are standard third-line or later treatments for advanced and recurrent colorectal cancer with no significant difference in efficacy. The present study aimed to compare the cost-effectiveness of using regorafenib vs. the trifluridine/...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Mol Clin Oncol
Prif Awduron: Kimura, Michio, Usami, Eiseki, Iwai, Mina, Go, Makiko, Teramachi, Hitomi, Yoshimura, Tomoaki
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: D.A. Spandidos 2016
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5103889/
https://ncbi.nlm.nih.gov/pubmed/27900102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.1020
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg